- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07802600
Clinical, Dermoscopic, and Mycological Characteristics of Tinea Capitis in Children
Clinical, Dermoscopic, and Mycological Characteristics of Tinea Capitis in Children: A Cross-sectional Study
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Clinical types of tinea capitis include : scaly type (characterized by fine scaling and circular alopecia), black dot (characterized by non-inflammatory patches with broken-off, swollen hair stubs), tinea agminate (patchy alopecia with scattered pustules or low-grade folliculitis), kerion (painful, boggy, inflammatory masses with alopecia, often confused with bacterial abscess) and favus (scutula, mousy odor) . Tinea incognito (steroid modified tinea) refers to dermatophytosis that has lost their usual clinical appearance due to the use of steroids.
The main clinical feature of dermatophyte scalp infections is the appearance of scaling of the scalp skin, which is associated with a variable degree of inflammation and itching . In some cases, the infection closely resembles seborrheic dermatitis or dandruff of the scalp. A pathognomonic feature is hair loss; hair often breaks a few millimeters or more above the skin surface. Broken or infected hairs are also slightly swollen and have a dull appearance .
Trichoscopy is a non-invasive and very useful technique for the diagnosis and follow-up of hair and scalp disorders. The presence of certain trichoscopic features allows accurate identifying of tinea capitis. In tinea capitis, specific signs can be seen like comma hair, corkscrew hair, bar code-like hair and zigzag hair . In tinea incognito trichoscopic finding include erythema, scaling, bent hair, Morse code hair, and micropustules .
Mycological examination was first performed using Potassium Hydroxide(KOH) to confirm the diagnosis of tinea capitis where the patients with positive KOH were considered to have endothrix when observing arthroconidia inside the hair shaft and ectothrix when observing arthroconidia outside the hair shaft. The fungal culture also done to accurately recognize the organism through inoculation of samples on Sabouraud medium agar (SDA) with and without chloramphenicol(nonspecific medium) . And Dermasel medium agar act as specific medium.
The increase in antifungal resistance has recently been observed worldwide and resistant strains of the dermatophytes T. rubrum and T. indotineae have spread globally, causing outbreaks of extensive, difficult to treat infections , so we need rapid and reliable diagnostic tools that provide clues regarding the causative organisms.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Noha Shafik, Assistant professor
- Número de teléfono: 01067261504
- Correo electrónico: nohasaber@med.sohag.edu.eg
Copia de seguridad de contactos de estudio
- Nombre: Walaa Hemdan Abu Alhassan, Demonstrator
Ubicaciones de estudio
-
-
-
Sohag, Egipto
- Faculty of Medicine , Sohag university
-
Contacto:
- Noha Shafik
- Número de teléfono: 01067261504
- Correo electrónico: nohasaber@med.sohag.edu.eg
-
Contacto:
- Walaa Hemdan
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
The study will be conducted at the Dermatology Outpatient Clinic in Sohag University Hospitals.
Study population: The study population will be all patients with tinea capitis both male and female in childhood period, Aged 1-18 years old
Descripción
Inclusion Criteria:
- Both male and female in childhood period (1-18 years) with tinea capitis
Exclusion Criteria:
- Topical or systemic antifungal medications one month prior to enrollment in the study
- Presence of systemic disease, such as hepatic,renal, cardiac, autoimmune diseases, or malignancy
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
patients with tinea capitis both male and female in childhood period
|
Specimen will be cultured on sabouraud's dextrose agar (SDA) at 25 -30 c for 2 to 4 weeks and another specimen will be cultured on a Dermasel agar base (Oxoid, UK), both supplemented with chloramphenicol and cycloheximide , staining the fungal colonies by Lactophenol cotton blue to help the examination of colonial morphology and microscopic examination of the macro-conidia allow the identification of the dermatophyte species and suitable treatment
Antifungal susceptibility testing will be performed to determine the specific sensitivity profiles of the fungal isolates.
Antifungal susceptibility testing will be performed using seven antifungal agents: Terbinafine, Itraconazole, Griseofulvin, Fluconazole, Ketoconazole, Vorioconole and Miconazole.
Dermatophytes colonies will be probed from Dermasel agar cultures.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Percentage of participants presenting with specific clinical patterns of tinea capitis
Periodo de tiempo: At the time of initial clinical evaluation
|
Clinical evaluation will be performed to identify and classify the presentation of tinea capitis lesions (e.g., scaly patches, black dots, kerion, favus).
|
At the time of initial clinical evaluation
|
|
Percentage of participants exhibiting specific dermoscopic features of tinea capitis
Periodo de tiempo: At the time of initial dermoscopic evaluation
|
Dermoscopic examination using a handheld dermatoscope to identify characteristic signs including comma hairs, corkscrew hairs, broken hairs, and scaling.
|
At the time of initial dermoscopic evaluation
|
|
Prevalence of isolated fungal species among pediatric tinea capitis cases
Periodo de tiempo: At the time of initial sample collection and culture identification
|
Mycological evaluation including direct microscopic KOH preparation and fungal culture on agar media to isolate and identify the causative fungal pathogens.
|
At the time of initial sample collection and culture identification
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Silla de estudio: Mohammed Abu El Hamd Ali, Faculty of Medicine , Sohag university
- Silla de estudio: Doaa Gaber Abdelbaset, Faculty of Medicine , Sohag university
Publicaciones y enlaces útiles
Enlaces Útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- Soh-Med-26-8-10MS
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .